Audit Committee Member
The Audit Committee’s role is to act on the behalf of PDA’s Board of Directors (“the Board”) and oversee all material aspects of the organization’s financial reporting, internal control and audit functions. The audit committee recommends the choice of external audit company for final approach by the Board of Directors. Committee members should have knowledge of the primary activities of the organization, the ability to read and understand non-profit financial statements and the ability to understand key operational and financial risks and related controls.
Committee Member Duties
- Review the results of the annual external audit and related comments including the management letter and required communication letter.
- Review changes in important accounting principles or matters that may have a material impact on the financial statements “identified by the external auditor” at the discretion for the Committee Chair.
Requirements
- Active PDA Membership
- Time Commitment: In-person meetings at least twice a year. Additional meetings may occur by phone.
- Serve Two year Term
One position available to be filled immediately.
Deadline
All submissions must be completed by 29 SEPTEMBER 2017.
Poster Presenter: 10th Workshop on Monoclonal Antibodies
Paper abstracts and posters must be non-commercial in nature, describing new developments or work that significantly contributes to the body of knowledge relating to Monoclonal Antibodies.
Case Studies are particularly desired. All submitted abstracts will be reviewed by the Scientific Program Planning Committee for acceptance. A more detailed draft presentation will be due for committee review one month prior to the conference to ensure scientific nature of the content. Abstracts not selected for a 30 minute podium presentation may be eligible as a scientific poster during the conference. Please note that additional presenters / authors or poster presenters will be subject to a registration fee.
https://www.pda.org/docs/default-source/website-document-library/eu-conferences/2017/10th-workshop-on-monoclonal-antibodies/call-for-papers.pdf
Deadline
All abstracts must be submitted by 5 SEPTEMBER 2017. Conference location: Berlin, Germany
Poster Presenter: Pharmaceutical Cold & Supply Chain Logistics
Paper abstracts and posters must be non-commercial in nature, describing new developments, case studies and/or work that significantly contribute to the body of knowledge relating to temperature controlled supply chain management of pharmaceuticals, vaccines and medical devices. Case studies are particularly desired. Commercial abstracts for papers or posters will not be considered. All submitted abstracts will be reviewed by the Scientific Program Planning Committee for acceptance. A more detailed draft presentation will be due for committee review one month prior to the conference to ensure scientific nature of the content. Abstracts not selected for a 30 minute podium presentation may be eligible as a scientific poster during the conference. Please note that additional presenters / authors or poster presenters will be subject to a registration fee.
For more information, navigate to the Poster Presenter: Pharmaceutical Cold & Supply Chain Logistics webpage.
Deadline
All abstracts must be submitted by 15 SEPTEMBER 2017. Conference location: Prague, Czech Republic.
Call for Paper: Pharmacopoeia Conference
Deadline
All abstracts must be submitted by 28 FEBRUARY 2018. Conference location: Vienna, Austria
For more information, navigate to the Pharmacopoeia webpage.
Call for Paper: Pharmacopoeia Conference
For more information, navigate to the Pharmacopoeia webpage. https://www.surveymonkey.de/r/2018Pharmacopoeia
Deadline
All abstracts must be submitted by 31 OCTOBER 2017. Conference location: Vienna, Austria
Poster Presenter: 2018 Annual Meeting
The Program Planning Committee encourages you to submit an abstract for a one-day poster presentation or an oral presentation at the 2018 PDA Annual Meeting. Case studies are particularly desired. Abstracts must be non-commercial, describe industry developments, strategies or practical implementation and contribute to the current body of knowledge for biopharmaceutical manufacturing, quality management and technology. Abstracts related to novel manufacturing and analytical technologies are preferable, but those addressing other bioprocessing topics are welcome.
Each abstract must include the following information to be considered:
- Full Name
- Professional Title
- Company
- Mailing Address
- Email Address
- Phone Number
- Biography (Max 200 words)
- Abstract Overview (Max 200 words)
- Abstract Title (Max 50 words)
- Abstract Objectives (Max 100 words)
- Audience Take Home Benefits (Max 100 words)
https://www.pda.org/docs/default-source/website-document-library/conferences/2018/call-for-abstracts
Deadline
All abstracts must be submitted by 18 September 2017 for consideration. Submitting an abstract confirms that an individual has received their company’s required approval to present if selected. Submitters will be advised in writing of the status of their abstract by October 18, 2017. To confirm participation and be listed in the final program, poster presenters are required to register as a paid full conference attendee, no later than January 19, 2018.
Poster Presenter: Universe Pre-Filled Syringe & Injection Devices
Abstracts for podium presentation must be non-commercial in nature, describing new developments or work that significantly contributes to the body of knowledge relating to prefilled syringes and injection devices.
Submissions received must include the following information:
- Title
- Presenter
- Presenter’s biography (approx. 100 words)
- Additional authors
- Full mailing address
- Phone number
- Fax number
- E-mail address of the presenter
- Key objectives of your topic
- 2-3 paragraph abstract, summarizing your topic
Deadline
All abstracts must be submitted by 29 September 2017. For more information, navigate to the Universe of Pre-filled Syringe Call of Abstracts webpage.
Peer Review: Developing a Control Strategy for Cell Therapies
The S&RA department is currently looking for individuals with cell therapy or ATMP production process development experience and/or regulatory authority personnel who evaluate cell therapy/ATMP processes. Anticipated start is Fall 2017.
Technology Case Study
The PDA Letter is looking for authors to write short case studies based on their experiences implementing new technologies into their operations. These could be in manufacturing, labwork, packaging, etc. We’re looking for 750-1000 word articles. We’re always looking for such authors so there is no deadline. Authors can be of any background and level of experience.
Author or Contribute to the PDA Journal of Pharmaceutical Science and Technology
Manuscripts are accepted at any time and can include letters to the editor, commentaries, reviews, original research, and technology/applications (e.g., case studies).
Learn more about being a PDA Journal of Pharmaceutical Science and Technology Author.
Instructor for PDA Education Courses
PDA Education is looking for individuals who would like to teach either a lecture, hands-on or laboratory course on an innovative topic or a course in one of PDA's areas of specialty, including:
- Aseptic Processing
- Biotechnology
- Combination Products
- Environmental Monitoring
- Filtration
- Microbiology
- Quality and Regulatory Affairs
- Supply Chain
- Training
- Validation
- Visual Inspection
If you are interested in teaching or have an idea for a new course, please send a cover letter and resume to
Karena Grigsby, Volunteer Coordinator, PDA.